Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 112

1.

Break-apart interphase fluorescence in situ hybridization assay in papillary thyroid carcinoma: on the road to optimizing the cut-off level for RET/PTC rearrangements.

Colato C, Vicentini C, Cantara S, Pedron S, Brazzarola P, Marchetti I, Di Coscio G, Chilosi M, Brunelli M, Pacini F, Ferdeghini M.

Eur J Endocrinol. 2015 May;172(5):571-82. doi: 10.1530/EJE-14-0930. Epub 2015 Feb 19.

PMID:
25698220
2.

Assessing RET/PTC in thyroid nodule fine-needle aspirates: the FISH point of view.

Caria P, Dettori T, Frau DV, Borghero A, Cappai A, Riola A, Lai ML, Boi F, Calò P, Nicolosi A, Mariotti S, Vanni R.

Endocr Relat Cancer. 2013 Jun 27;20(4):527-36. doi: 10.1530/ERC-13-0157. Print 2013 Aug.

PMID:
23722226
3.

An evaluation and recommendation of the optimal methodologies to detect RET gene rearrangements in papillary thyroid carcinoma.

Zhang T, Lu Y, Ye Q, Zhang M, Zheng L, Yin X, Gavine P, Sun Z, Ji Q, Zhu G, Su X.

Genes Chromosomes Cancer. 2015 Mar;54(3):168-76. doi: 10.1002/gcc.22229. Epub 2014 Nov 19.

PMID:
25407564
4.

Diffuse sclerosing variant of papillary thyroid carcinoma: major genetic alterations and prognostic implications.

Joung JY, Kim TH, Jeong DJ, Park SM, Cho YY, Jang HW, Jung YY, Oh YL, Yim HS, Kim YL, Chung JH, Ki CS, Kim SW.

Histopathology. 2016 Jul;69(1):45-53. doi: 10.1111/his.12902. Epub 2016 Jan 11.

PMID:
26568156
5.

Concomitant BRAF(V600E) mutation and RET/PTC rearrangement is a frequent occurrence in papillary thyroid carcinoma.

Guerra A, Zeppa P, Bifulco M, Vitale M.

Thyroid. 2014 Feb;24(2):254-9. doi: 10.1089/thy.2013.0235. Epub 2013 Aug 24.

PMID:
23806056
6.

Heterogeneity in the distribution of RET/PTC rearrangements within individual post-Chernobyl papillary thyroid carcinomas.

Unger K, Zitzelsberger H, Salvatore G, Santoro M, Bogdanova T, Braselmann H, Kastner P, Zurnadzhy L, Tronko N, Hutzler P, Thomas G.

J Clin Endocrinol Metab. 2004 Sep;89(9):4272-9.

PMID:
15356021
7.

RET rearrangements in papillary thyroid carcinomas and adenomas detected by interphase FISH.

Cinti R, Yin L, Ilc K, Berger N, Basolo F, Cuccato S, Giannini R, Torre G, Miccoli P, Amati P, Romeo G, Corvi R.

Cytogenet Cell Genet. 2000;88(1-2):56-61.

PMID:
10773666
8.

Chromosomal rearrangements in post-Chernobyl papillary thyroid carcinomas: evaluation by spectral karyotyping and automated interphase FISH.

Hieber L, Huber R, Bauer V, Schäffner Q, Braselmann H, Thomas G, Bogdanova T, Zitzelsberger H.

J Biomed Biotechnol. 2011;2011:693691. doi: 10.1155/2011/693691. Epub 2011 Mar 13.

9.

Detection of PAX8/PPARG and RET/PTC rearrangements is feasible in routine air-dried fine needle aspiration smears.

Ferraz C, Rehfeld C, Krogdahl A, Precht Jensen EM, Bösenberg E, Narz F, Hegedüs L, Paschke R, Eszlinger M.

Thyroid. 2012 Oct;22(10):1025-30. doi: 10.1089/thy.2011.0391.

10.

Clinical, genetic, and immunohistochemical characterization of 70 Ukrainian adult cases with post-Chornobyl papillary thyroid carcinoma.

Dinets A, Hulchiy M, Sofiadis A, Ghaderi M, Höög A, Larsson C, Zedenius J.

Eur J Endocrinol. 2012 Jun;166(6):1049-60. doi: 10.1530/EJE-12-0144. Epub 2012 Mar 28.

11.

RET/PTC Rearrangements Are Associated with Elevated Postoperative TSH Levels and Multifocal Lesions in Papillary Thyroid Cancer without Concomitant Thyroid Benign Disease.

Su X, He C, Ma J, Tang T, Zhang X, Ye Z, Long Y, Shao Q, Shao J, Yang A.

PLoS One. 2016 Nov 1;11(11):e0165596. doi: 10.1371/journal.pone.0165596. eCollection 2016.

12.

[Expressions of wildtype-RET and RET/PTC rearrangements in sporadic adult papillary thyroid carcinoma and their clinicopathologic correlation].

Zhu XL, Zhou XY, Zhang TM, Zhu XZ.

Zhonghua Bing Li Xue Za Zhi. 2006 Feb;35(2):87-91. Chinese.

PMID:
16630482
13.

[RET/PTC rearrangement affects multifocal formation of papillary thyroid carcinoma].

Zhang X, Su X, Chen WC, Li Y, Yang ZY, Deng WZ, Deng TC, Yang AK.

Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi. 2017 Jun 7;52(6):435-439. doi: 10.3760/cma.j.issn.1673-0860.2017.06.008. Chinese.

PMID:
28635216
14.

Optimizing detection of RET and PPARg rearrangements in thyroid neoplastic cells using a home-brew tetracolor probe.

Caria P, Frau DV, Dettori T, Boi F, Lai ML, Mariotti S, Vanni R.

Cancer Cytopathol. 2014 May;122(5):377-85. doi: 10.1002/cncy.21397. Epub 2014 Feb 7.

15.

Overexpression of wild-type c-RET and zero prevalence of RET/PTC rearrangements are associated with papillary thyroid cancer (PTC) in Kuwait.

El-Abdallah AA, Junaid TA.

Exp Mol Pathol. 2011 Feb;90(1):61-5. doi: 10.1016/j.yexmp.2010.10.002. Epub 2010 Oct 13.

PMID:
20950609
16.

Prevalence of RET/PTC1 and RET/PTC3 gene rearrangements in Chennai population and its correlation with clinical parameters.

Rao PJ, Vardhini NV, Parvathi MV, Murthy PB, Sudhakar G.

Tumour Biol. 2014 Oct;35(10):9539-48. doi: 10.1007/s13277-014-1909-x. Epub 2014 Jun 24.

PMID:
24957039
17.

BRAFV600E mutation, but not RET/PTC rearrangements, is correlated with a lower expression of both thyroperoxidase and sodium iodide symporter genes in papillary thyroid cancer.

Romei C, Ciampi R, Faviana P, Agate L, Molinaro E, Bottici V, Basolo F, Miccoli P, Pacini F, Pinchera A, Elisei R.

Endocr Relat Cancer. 2008 Jun;15(2):511-20. doi: 10.1677/ERC-07-0130.

PMID:
18509003
18.

RET/papillary thyroid cancer rearrangement in nonneoplastic thyrocytes: follicular cells of Hashimoto's thyroiditis share low-level recombination events with a subset of papillary carcinoma.

Rhoden KJ, Unger K, Salvatore G, Yilmaz Y, Vovk V, Chiappetta G, Qumsiyeh MB, Rothstein JL, Fusco A, Santoro M, Zitzelsberger H, Tallini G.

J Clin Endocrinol Metab. 2006 Jun;91(6):2414-23. Epub 2006 Apr 4.

PMID:
16595592
19.

Frequent RET rearrangements in thyroid papillary microcarcinoma detected by interphase fluorescence in situ hybridization.

Corvi R, Martinez-Alfaro M, Harach HR, Zini M, Papotti M, Romeo G.

Lab Invest. 2001 Dec;81(12):1639-45.

PMID:
11742034
20.

Absence of BRAF, NRAS, KRAS, HRAS mutations, and RET/PTC gene rearrangements distinguishes dominant nodules in Hashimoto thyroiditis from papillary thyroid carcinomas.

Sadow PM, Heinrich MC, Corless CL, Fletcher JA, Nosé V.

Endocr Pathol. 2010 Jun;21(2):73-9. doi: 10.1007/s12022-009-9101-3.

PMID:
20012784

Supplemental Content

Support Center